Showing results (151-160 of 194) with videos related to
Sort By:
Pageof 20
Neuroscience Letters|March 31, 1995
Apolipoprotein E allelic frequencies in patients with lobar atrophyS M Pickering-Brown, M Siddons, D M Mann, et al.Neurobiology of Aging|January 1, 1992
Lectin histochemistry of cerebral microvessels in ageing, Alzheimer's disease and Down's syndromeD M Mann, M S Purkiss, R E Bonshek, et al.Archives of Neurology|September 17, 1999
Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer diseaseC F Lippa, K Ozawa, D M Mann, et al.Neuropathology and Applied Neurobiology|July 1, 1989
An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniquesD M Mann, A Brown, D Prinja, et al.Journal of the Neurological Sciences|March 1, 1987
Somatostatin content and release measured in cerebral biopsies from demented patientsP T Francis, D M Bowen, S L Lowe, et al.The Journal of Clinical Investigation|February 7, 1998
Decorin suppresses tumor cell growth by activating the epidermal growth factor receptorD K Moscatello, M Santra, D M Mann, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementiaA R Varma, J S Snowden, J J Lloyd, et al.Neuroscience Letters|January 17, 1997
Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 alleleD M Mann, T Iwatsubo, S M Pickering-Brown, et al.Neuroscience Letters|May 18, 1990
Cerebral cortical calbindin D28K and parvalbumin neurones in Down's syndromeK Kobayashi, P C Emson, C Q Mountjoy, et al.Brain Research|October 11, 1988
Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brainsM D Simpson, M C Royston, J F Deakin, et al.Pageof 20